Diagnostic Medical Systems - Shares From Reverse

LTS:0RIA (France)   Shares From Reverse Split
€ 1.33 (0%) Apr 23
At Loss
P/B:
1.40
Market Cap:
€ 17.40M ($ 18.61M)
Enterprise V:
€ 27.97M ($ 29.93M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Diagnostic Medical Systems ( LTS:0RIA ) from 2007 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Diagnostic Medical Systems stock (LTS:0RIA) PE ratio as of Apr 24 2024 is 0. More Details

Diagnostic Medical Systems (LTS:0RIA) PE Ratio (TTM) Chart

To

Diagnostic Medical Systems (LTS:0RIA) PE Ratio (TTM) Historical Data

Total 1256
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Diagnostic Medical Systems PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-23 At Loss 2024-02-19 At Loss
2024-04-22 At Loss 2024-02-16 At Loss
2024-04-19 At Loss 2024-02-15 At Loss
2024-04-18 At Loss 2024-02-14 At Loss
2024-04-17 At Loss 2024-02-13 At Loss
2024-04-16 At Loss 2024-02-12 At Loss
2024-04-15 At Loss 2024-02-09 At Loss
2024-04-12 At Loss 2024-02-08 At Loss
2024-04-11 At Loss 2024-02-07 At Loss
2024-04-10 At Loss 2024-02-06 At Loss
2024-04-09 At Loss 2024-02-05 At Loss
2024-04-08 At Loss 2024-02-02 At Loss
2024-04-05 At Loss 2024-02-01 At Loss
2024-04-04 At Loss 2024-01-31 At Loss
2024-04-03 At Loss 2024-01-30 At Loss
2024-04-02 At Loss 2024-01-29 At Loss
2024-03-29 At Loss 2024-01-26 At Loss
2024-03-28 At Loss 2024-01-25 At Loss
2024-03-27 At Loss 2024-01-24 At Loss
2024-03-26 At Loss 2024-01-23 At Loss
2024-03-25 At Loss 2024-01-22 At Loss
2024-03-22 At Loss 2024-01-19 At Loss
2024-03-21 At Loss 2024-01-18 At Loss
2024-03-20 At Loss 2024-01-17 At Loss
2024-03-19 At Loss 2024-01-16 At Loss
2024-03-18 At Loss 2024-01-15 At Loss
2024-03-15 At Loss 2024-01-12 At Loss
2024-03-14 At Loss 2024-01-11 At Loss
2024-03-13 At Loss 2024-01-10 At Loss
2024-03-12 At Loss 2024-01-09 At Loss
2024-03-11 At Loss 2024-01-08 At Loss
2024-03-08 At Loss 2024-01-05 At Loss
2024-03-07 At Loss 2024-01-04 At Loss
2024-03-06 At Loss 2024-01-03 At Loss
2024-03-05 At Loss 2024-01-02 At Loss
2024-03-04 At Loss 2024-01-01 At Loss
2024-03-01 At Loss 2023-12-29 At Loss
2024-02-29 At Loss 2023-12-28 At Loss
2024-02-28 At Loss 2023-12-27 44.4
2024-02-27 At Loss 2023-12-25 44.4
2024-02-26 At Loss 2023-12-22 44.4
2024-02-23 At Loss 2023-12-21 44.4
2024-02-22 At Loss 2023-12-20 44.4
2024-02-21 At Loss 2023-12-19 44.4

Diagnostic Medical Systems (LTS:0RIA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Diagnostic Medical Systems

ISIN : FR0012202497

Share Class Description:

LTS:0RIA: Shares From Reverse Split
Description
Diagnostic Medical Systems formerly Diagnostic Medical Systems SA is a French high-tech company based in the south of France. It is specialized in medical imaging diagnostics. The company's brand include Apelem, DMS, AXS Medical and Medilink that offer a complete range of innovative solutions in radiology, bone densitometry, stereo-radiography and posturology.